Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RUCAPARIB for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where RUCAPARIB was used for Neoplasm.

Most Reported Side Effects for RUCAPARIB

Side Effect Reports % Deaths Hosp.
Anaemia 49 11.3% 2 37
Acute kidney injury 34 7.8% 6 34
Febrile neutropenia 33 7.6% 2 33
Fatigue 32 7.4% 1 10
Nausea 30 6.9% 0 15
Pancytopenia 27 6.2% 2 24
Diarrhoea 23 5.3% 1 18
Drug ineffective 22 5.1% 6 1
Vomiting 20 4.6% 0 16
Abdominal pain 17 3.9% 0 15
Thrombocytopenia 17 3.9% 4 12
Constipation 15 3.5% 0 5
Malignant neoplasm progression 15 3.5% 8 6
Pyrexia 13 3.0% 0 11
Decreased appetite 12 2.8% 0 3

Other Indications for RUCAPARIB

Ovarian cancer (201) Prostate cancer metastatic (34) Small cell lung cancer (29) Hormone-refractory prostate cancer (27) Prostate cancer (27) Endometrial cancer (15) Product used for unknown indication (12) Fallopian tube cancer (9) Neoplasm malignant (9) Malignant peritoneal neoplasm (7)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

RUCAPARIB Full Profile All Neoplasm Drugs RUCAPARIB Demographics RUCAPARIB Timeline